Anderson, K. M., & Gayer, C. P. (2021). The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. MDPI AG.
Cita Chicago Style (17a ed.)Anderson, Kemp M., y Christopher P. Gayer. The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. MDPI AG, 2021.
Cita MLA (8a ed.)Anderson, Kemp M., y Christopher P. Gayer. The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.